A study recently published in Proceedings of the National Academy of Sciences provides further demonstration that implanting encapsulated beta cells can be beneficial to individuals with T1D. In the study, researchers implanted functional islet cells from the pancreas of a deceased organ donor into a 63-year-old man who had had T1D for 54 years and who showed no evidence of residual beta cell function.

Read more